Sandip Kapadia
CIK 1677141 · CHIEF FINANCIAL OFFICER · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$845.0K
Companies
3
Total Filings
45
Lifetime Open-Market Net
-$4.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 0 | $5.81 | $0 | $84.0K | 9 | 2026-05-21 |
| HRMY | CHIEF FINANCIAL OFFICER | 24,521 | $34.46 | $845.0K | -$3.89M | 17 | 2026-01-28 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | CFO and Treasurer | 40,964 | $19.00 | $778.3K | -$306.3K | 19 | 2021-01-26 |
Recent Filings · Page 3 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-02 | PASG | Sell (S) | −5,000 | -$6.0K | EDGAR |
| 2022-05-31 | PASG | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | PASG | Grant (A) | — | $0 | EDGAR |
| 2021-03-31 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2021-01-26 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +17,200 | $0 | EDGAR |
| 2021-01-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −3,394 | -$83.3K | EDGAR |
| 2020-12-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −1,763 | -$57.8K | EDGAR |
| 2020-10-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −296 | -$12.5K | EDGAR |
| 2020-07-06 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −615 | -$28.6K | EDGAR |
| 2020-04-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −615 | -$35.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.